PATENT CLAIM ANALYSIS

Application Number: 15960759
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "264110"]

Abstract:
Novel azaquinazoline carboxamide derivatives of formula (I) wherein W 1 , W 2 , W 3 , W 4 , R 1 , R 2 , R 3  and m which are defined above, are p70S6K inhibitor, and can be employed, inter alia, for the treatment of hyperproliferative disorders.

Claim (Index 1):
A compound of formula (I) wherein\n W 1  is CH; \n W 2  is CH; \n W 3  is N; \n W 4  is CH; or \n W 1  is CH; \n W 2  is CH; \n W 3  is CH; \n W 4  is N; \n R 1  is Ar or Het 1 ; \n each of R 2 , R 4 , and R 5  is independently Y; \n R 3  is Y or \u2014(CH 2 ) p \u2014NR 4 R 5 ; \n or R 2  and R 3  together with the atoms to which each is attached, may form \u2014(CH 2 ) n \u2014NY\u2014(CH 2 ) p ; \n or R 4  and R 5  together with the atoms to which each is attached, may form \u2014(CY 2 ) q \u2014; \n each Y is independently H or A; \n each A is independently unbranched or branched alkyl having 1-10 C atoms, in which 1-7 H atoms can be replaced independently from one another by Hal; \n Ar is an unsaturated or aromatic mono- or bicyclic carbocycle having 3-10 C atoms, which can be substituted by at least one substituent selected from the group of Hal, A, OY, CN, COY, COOY, CONYY, NYCOY, NYCONYY, SO 2 Y, SO 2 NYY, NYSO 2 Y, NYY, NO 2 , OCN, SCN, SH, optionally substituted phenyl and Het 1 ; \n each Het 1  is independently an unsaturated or aromatic mono- or bicyclic heterocycle having 2-10 C atoms and 1-4 N, O and/or S atoms, which can be substituted by at least one substituent selected from the group of Hal, A, OY, CN, COY, COOY, CONYY, NYCOY, NYCONYY, SO 2 Y, SO 2 NYY, NYSO 2 Y, NYY, NO 2 , OCN, SCN, SH, optionally substituted phenyl and Het 2 ; \n Het 2  is an optionally substituted, saturated, unsaturated or aromatic monocyclic 5-6-membered heterocycle having 2-5 C atoms and 1-3 N, O and/or S atoms; \n each Hal is independently F, Cl, Br or I; \n m is 0 or 1; \n each of n and p is independently 0, 1, 2 or 3; and \n q is 2, 3, 4, 5 or 6; \n and/or a physiologically acceptable salt thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 91.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15227638', '14432618', '14432316', '14105974', '15277479']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8227990214283343
- 35 USC 102 Novelty (BERT): 0.555434400438946
- Combined Prediction Score: 0.7960625593293954
- Mean Citation Score: 365.420782
- Max Citation Score: 434.38058
- Similarity Product: 312.929157429266

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test